spironolactone has been researched along with Tricuspid Valve Stenosis in 1 studies
Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.
Tricuspid Valve Stenosis: The pathologic narrowing of the orifice of the TRICUSPID VALVE. This hinders the emptying of RIGHT ATRIUM leading to elevated right atrial pressure and systemic venous congestion. Tricuspid valve stenosis is almost always due to RHEUMATIC FEVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Extrinsic tricuspid valve stenosis was detected by transthoracic echocardiography." | 1.46 | [Heart failure provoked by a pacemaker lead-induced tricuspid stenosis]. ( Chaudesaygues, E; Ferrini, M; Ritz, B, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaudesaygues, E | 1 |
| Ferrini, M | 1 |
| Ritz, B | 1 |
1 other study available for spironolactone and Tricuspid Valve Stenosis
| Article | Year |
|---|---|
[Heart failure provoked by a pacemaker lead-induced tricuspid stenosis].
Topics: Aged; Angiography; Diuretics; Echocardiography; Furosemide; Heart Failure; Humans; Male; Pacemaker, | 2017 |